Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories. WOBURN, Mass., Sept. 8, 2025 /PRNewswire/ --…
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma…
June 06, 2025 16:01 ET Â | Source: Replimune Group Inc WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…